Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis

ClinicalTrials.gov ID: NCT04693195

Public ClinicalTrials.gov record NCT04693195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 28, 2026, 11:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety, and Tolerability of BLU-5937 for the Treatment of Chronic Pruritus in Adult Subjects With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled, parallel design study of BLU-5937 for the treatment of chronic pruritus in adult subjects with atopic dermatitis (AD).

Study identification

NCT ID
NCT04693195
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
142 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2020
Primary completion
Oct 3, 2021
Completion
Oct 11, 2021
Last update posted
Oct 16, 2022

2020 – 2021

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Bellus Health Investigational Site #28 Phoenix Arizona 85032 —
Bellus Health Investigational Site #10 Scottsdale Arizona 85254 —
Bellus Health Investigational Site #23 Beverly Hills California 90212 —
Bellus Health Investigational Site #33 Encinitas California 92024 —
Bellus Health Investigational Site #27 Fountain Valley California 92708 —
Bellus Health Investigational Site #35 San Diego California 92123 —
Bellus Health Investigational Site #15 Hialeah Florida 33012 —
Bellus Health Investigational Site #32 Margate Florida 33063 —
Bellus Health Investigational Site #16 Miami Florida 33125 —
Bellus Health Investigational Site #19 Miami Florida 33136 —
Bellus Health Investigational Site #17 Sweetwater Florida 33172 —
Bellus Health Investigational Site #24 Savannah Georgia 31406 —
Bellus Health Investigational Site #13 Owensboro Kentucky 42301 —
Bellus Health Investigational Site #38 Baton Rouge Louisiana 70809 —
Bellus Health Investigational Site #45 Covington Louisiana 70433 —
Bellus Health Investigational Site #18 New Orleans Louisiana 70115 —
Bellus Health Investigational Site #36 Minneapolis Minnesota 55402 —
Bellus Health Investigational Site #22 Portsmouth New Hampshire 03801 —
Bellus Health Investigational Site #34 New York New York 10075 —
Bellus Health Investigational Site #14 High Point North Carolina 27262 —
Bellus Health Investigational Site #29 Norman Oklahoma 73071 —
Bellus Health Investigational Site #37 Newtown Square Pennsylvania 19073 —
Bellus Health Investigational Site #41 Rapid City South Dakota 57702 —
Bellus Health Investigational Site #12 Austin Texas 78759 —
Bellus Health Investigational Site #31 College Station Texas 77845 —
Bellus Health Investigational Site #40 San Antonio Texas 78213 —
Bellus Health Investigational Site #11 San Antonio Texas 78229 —
Bellus Health Investigational Site #25 Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04693195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2022 · Synced Sep 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04693195 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →